Why know the odds if they're useless?
An Extraordinary Healer essay honoring Sharon Bird, BSN, RN [ THOMAS JEFFERSON UNIVERSITY HOSPITAL IN RADNOR, PENNSYLVANIA ]
This essay describes my journey with non-Hodgkin lymphoma — peripheral T-cell, not otherwise specified — and my most extraordinary nurse, Xuan Arnette, RN, OCN.
Individuals who were screened for hereditary cancer risk in the past might benefit from getting tested again using today’s more sophisticated panels.
When the USPSTF issued its recommendation against PSA testing, urologists nationwide, myself included, warned about the possible public health repercussions that could ensue. Our fears have materialized, and much sooner than anticipated.
A long-term cancer survivor shares her tips on getting through the winter cold that bites a little extra for survivors and patients with cancer.
One person with cancer details their challenges with fighting for social security while battling a metastatic breast cancer diagnosis.
The Leukemia and Lymphoma Society's "First Connection" program connects volunteers with newly diagnosed patients and caregivers to help them manage the many aspects of a cancer diagnosis.
Alicia Staley, survivor and patient advocacy manager of Cure Forward, discusses the potential use of social media to recruit for clinical trials for new cancer treatment.
The winner of the CURE® Extraordinary Healer® Award for Oncology Nursing discussed the bonds formed between patients with cancer and their health care team.
Cancer doesn’t discriminate. It doesn’t care what race, gender, ethnicity, sexuality or even age you are. It takes no prisoners. And it certainly did not take me. I continue to remain resilient despite what I’ve been through and despite what still may be on the horizon.
An Extraordinary Healer essay honoring JENNIFER HOLTON, B.S.N., RN, OCN [TEXAS ONCOLOGY — PLANO WEST, PLANO, TEXAS]
Surgical oncologist Kelly K. Hunt, of MD Anderson Cancer Center, discusses how breast cancer interventions have progressed in the adjuvant and neoadjuvant setting and the role of sentinel lymph node dissection in the neoadjuvant setting.
Paul B. Jacobsen, Associate Center Director for Population Science at Moffitt Cancer Center, comments on preserving fertility for patients with cancer.
The doctors and researchers at the Penn Pancreatic Cancer Research Center (Perelman School of Medicine at the University of Pennsylvania) examine different aspects of pancreatic cancer to find better treatments.
This research was presented at the 2016 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of over 30,000 oncology professionals in Chicago.
“There's a lot of miscommunication and number one, I would tell them you don't need to face these decisions alone,” Dr. Pat Basu said in an interview addressing patient’s fear in the midst of the COVID-19 pandemic.
“‘Compassionate,’ “cheerleader,’ ‘friend’ ‘supporter’ and ‘angel’ are just a few words used by patients and staff to describe Harding Cranford, RN, OCN,” wrote Erin Auten, RN.
Dr. Matthew Galsky highlights the impact of Imfinzi’s adjuvant approval for patients with muscle-invasive bladder cancer following cystectomy and chemo.
New drug treatments are helping patients with advanced prostate cancer to live longer.
Gregory J. Riely, associate attending physician, Memorial Sloan Kettering Cancer Center, discusses identifying and treating patients with MET exon 14 skipping mutations in lung cancer.
Nita Karnik Lee, MD, MPH, of The University of Chicago Medicine, discusses what patients with ovarian cancer should know about when entering survivorship.
To ease ‘chemo brain,’ a nurse researcher combined mindfulness with physical exercise.
Apps and online resources can help the mind, body and soul.
How a cancer diagnosis leaves one woman feeling humbled.
After her daughter was diagnosed, Celia Miltz founded the Friends of ET Research.
Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, and Sara A. Hurvitz, M.D., discuss treatment approaches and modifications during the COVID-19 pandemic.